NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.
CASRN: 737-31-5

Drug Levels and Effects
Summary of Use during Lactation
Intravenous iodinated contrast media are poorly excreted into breastmilk and poorly absorbed orally so they are not likely to reach the bloodstream of the infant or cause any adverse effects in breastfed infants. Guidelines developed by several professional organizations state that breastfeeding need not be disrupted after a nursing mother receives a iodine-containing contrast medium.[1][2][3][4] However, because there is no published experience with iothalamate during breastfeeding, other agents may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
References
- 1.
- American College of Radiology Committee on Drugs and Contrast Media. Administration of contrast media to breast-feeding mothers. In, ACR manual on contrast media. 2017;Version 10.3:102-3. https://www
.acr.org/~ /media/37D84428BF1D4E1B9A3A2918DA9E27A3.pdf. - 2.
- Webb JA, Thomsen HS, Morcos SK et al. The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol. 2005;15:1234-40. [PubMed: 15609057]
- 3.
- Chen MM, Coakley FV, Kaimal A, Laros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112:333-40. [PubMed: 18669732]
- 4.
- Committee Opinion No. 723: Guidelines for Diagnostic Imaging During Pregnancy and Lactation. Obstet Gynecol. 2017;130:e210-e216. [PubMed: 28937575]
Substance Identification
Substance Name
Iothalamate
CAS Registry Number
737-31-5
Drug Class
- Breast Feeding
- Diagnostic Media
- Contrast Agents
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- PubMedLinks to PubMed
- Review Diatrizoate[Drugs and Lactation Database (...]Review Diatrizoate. Drugs and Lactation Database (LactMed). 2006
- Review Iodipamide[Drugs and Lactation Database (...]Review Iodipamide. Drugs and Lactation Database (LactMed). 2006
- Review Ioxaglate[Drugs and Lactation Database (...]Review Ioxaglate. Drugs and Lactation Database (LactMed). 2006
- Review Iothalamate Sodium I 125[Drugs and Lactation Database (...]Review Iothalamate Sodium I 125. Drugs and Lactation Database (LactMed). 2006
- Review Iopromide[Drugs and Lactation Database (...]Review Iopromide. Drugs and Lactation Database (LactMed). 2006
- Iothalamate - Drugs and Lactation Database (LactMed)Iothalamate - Drugs and Lactation Database (LactMed)
Your browsing activity is empty.
Activity recording is turned off.
See more...